8 Results for 'hematti'
PAGE 1 OF 1
Technology
T CELL SPECIFIC BIOMARKERS FOR PREDICTING GRAFT-VS-HOST DISEASE AND HEMATOPOIETIC MALIGNANCY RELAPSE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION AND TREATMENT THEREOF
UW-Madison researchers have identified and validated a set of human T cell specific biomarkers that can predicti graft-vs-host disease (GVHD) and/or relapse following allogeneic hematopoietic stem cel...
Learn More
Learn More
Christian Capitini, Nicholas Hess, Kalyan Nadiminti, Peiman Hematti, Jenny Gumperz | P220161US02
Technology
Mesenchymal Stem Cell-Educated Macrophages to Treat Radiation Damage and More
New therapies are urgently needed to protect patients exposed to high doses of radiation due to accidental trauma, terrorist attack or for medical purposes. Existing drugs (such as potassium iodide an...
Learn More
Learn More
Peiman Hematti, Myriam Bouchlaka, Christian Capitini | P140399US02
Technology
Macrophage Cell Therapy To Treat Orthopedic Injury
An ex vivo generated population of tissue-specific alternatively-activated macrophages and methods of making and using such macrophages for treating orthopedic injury are provided.
Learn More
Learn More
Peiman Hematti, Connie Chamberlain, Anna Clements, Ray Vanderby, John Kink | P170220US02
Technology
Effective and Robust Method of T Cell Expansion and Activation
Ex vivo expansion and activation of T cells are prerequisites for any form of genetically engineered T cell immunotherapy. Several expansion and activation methodologies have been developed. However, ...
Learn More
Learn More
Peiman Hematti, Debra Bloom | P150198US02
Technology
Generation Of Therapeutic Cells Using Extracellular Components Of Target Organs
The invention relates to an ex vivo generated population of tissue-specific anti-inflammatory macrophages and methods of making and using such macrophages.
Learn More
Learn More
Peiman Hematti, John Kink, Eric Schmuck, Amish Raval | P160278US01
Technology
LPS Priming of Stromal Cells to Generate LPS-specific Exosome Educated Macrophages
Currently there are no cell therapies approved for use against acute radiation injury (ARS). Severe ARS can cause death and the only cell treatment is allogenic bone marrow transplantation (BMT). Unfo...
Learn More
Learn More
Peiman Hematti, John Kink, Christian Capitini | P170215US02
Technology
Xeno-Free Generation Of Tissue-Specific Progenitor Cells
The invention relates to purified, tissue-specific progenitors, methods of making and using such tissue-specific progenitors.
Learn More
Learn More
Peiman Hematti, Jaehyup Kim | P100234US02
Technology
Anti-Inflammatory Macrophages And Uses Thereof
The invention relates to a purified, novel anti-inflammatory population of macrophage and methods of making and using such macrophage.
Learn More
Learn More
Peiman Hematti, Jaehyup Kim | P09357US02